Slow compartment features and gas exchange impairment in mild asthma: effects of beta agonist inhalation. 1998

S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
Servizio di Fisiopatologia Respiratoria, Università Cattolica Sacro Cuore, Roma, Italia.

Static and dynamic lung volumes, arterial blood gases, alveolar ventilation and ventilation-perfusion (VA/Q) relationships were studied in 14 mild asthmatic patients and in 7 normal subjects (as controls) before and after fenoterol inhalation. Multiple nitrogen washout curves were analyzed by a bicompartmental distribution model, in order to assess the distribution of ventilation and VA/Q mismatch. At baseline, asthmatics showed mild airway obstruction and gas exchange impairment [forced expiratory volume in 1 s (FEV1) = 79% pred; PaO2 = 87.4; alveolar-arterial oxygen tension gradient (AaPO2) = 22.9 mm Hg]. By analysing nitrogen washout curves, an alveolar slow space representing 45.1% of total lung volume (vs. 36.8% in normals; p = 0.044) was identified; its alveolar ventilation per minute per unit lung volume (VA2/L2) was lower than in normals (p = 0.01). beta-Agonist inhalation by the asthmatics, which reversed airway obstruction (FEV1 = 98% pred.; p < 0.001) and improved gas exchange (PaO2 = 92.6 mm Hg, p < 0.001; AaPO2 = 16.8 mm Hg, p = 0.003), led to a highly significant increase in VA2/L2 (p = 0.001). The improvement in PaO2 was associated with the increase in VA2/L2 (r2 = 0.39; p = 0.017), but not with the increase in FEV1. Lastly, the changes in FEV1 and VA2/L2 were not correlated with each other. We conclude that even in mild stable asthma there is substantial unevenness of ventilation, detectable by bicompartmental analysis of nitrogen washout curves, which is responsible for gas exchange impairment and is not related to common spirometric parameters. In addition, the improvement in gas exchange is probably due to the effect of fenoterol on the tributary airways of the alveolar slow compartment. This effect can be assessed by this simple method, which can be used in clinical pharmacology studies and in the follow-up of asthmatic patients.

UI MeSH Term Description Entries
D008176 Lung Volume Measurements Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle. Lung Capacities,Lung Volumes,Capacity, Lung,Lung Capacity,Lung Volume,Lung Volume Measurement,Measurement, Lung Volume,Volume, Lung
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011659 Pulmonary Gas Exchange The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER. Exchange, Pulmonary Gas,Gas Exchange, Pulmonary
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001784 Blood Gas Analysis Measurement of oxygen and carbon dioxide in the blood. Analysis, Blood Gas,Analyses, Blood Gas,Blood Gas Analyses,Gas Analyses, Blood,Gas Analysis, Blood
D005260 Female Females
D005280 Fenoterol A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. Berotec,Berotek,Fenoterol Hydrobromide,Fenoterol Hydrochloride,Partusisten,Phenoterol,Th-1165a,p-Hydroxyphenyl-orciprenaline,p-Hydroxyphenylorciprenaline,Hydrochloride, Fenoterol,Th 1165a,Th1165a,p Hydroxyphenyl orciprenaline,p Hydroxyphenylorciprenaline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol

Related Publications

S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
June 1970, The New England journal of medicine,
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
January 1990, International journal of clinical pharmacology research,
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
August 1994, American journal of respiratory and critical care medicine,
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
November 2012, The Journal of asthma : official journal of the Association for the Care of Asthma,
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
August 1989, Acta chirurgica Scandinavica,
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
April 2001, The European respiratory journal,
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
September 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
November 2008, Journal of applied physiology (Bethesda, Md. : 1985),
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
July 1997, American journal of respiratory and critical care medicine,
S Valente, and M De Rosa, and G M Corbo, and A Carlucci, and G Fumagalli, and G Ciappi
May 2002, The European respiratory journal,
Copied contents to your clipboard!